sar425899 dual agonist glp-1 glucagon sanofi Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity Design of Novel Exendin-Based Dual
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19



















